Test Price
2,800 AED✅ Home Collection Available
PIEZO2 Gene Distal Arthrogryposis Type 5 (DA5) Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary — The PIEZO2 gene sequencing test delivers diagnostic clarity for Distal Arthrogryposis Type 5 with 99.9% sensitivity, using next-generation sequencing technology at a DHA-licensed facility. Results are correlated with clinical presentation, family history, and imaging to guide multidisciplinary care planning.
- Accuracy Guarantee: 99.9% diagnostic sensitivity with full gene coverage (exons + intron boundaries) via ISO 9001:2015 accredited processing and ClinVar-validated variant interpretation.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary telephonic post-test interpretation by a DHA-licensed consultant medical geneticist.
- Insurance: Direct billing verification available via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The PIEZO2 Gene Distal Arthrogryposis Type 5 NGS Test uses next-generation sequencing on the Illumina platform to decode the full PIEZO2 locus at greater than 1000x read depth. It identifies pathogenic mutations associated with congenital contractures, cleft palate, and aberrant papillary ridges. This test is ordered by clinical geneticists, orthopedic surgeons, or dermatologists when a child presents with characteristic limb deformities and syndromic features.
| Feature | Our Test (ISO Certified) | Closest Alternative (Research Lab) |
|---|---|---|
| Precision | 99.9% Sensitivity, full gene coverage (exons + intron boundaries) | Often limited to hot-spot screening |
| Methodology | NGS with Illumina platform, >1000x read depth | Sanger sequencing (partial) |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
Physician Insight & Safety Protocols
“A positive PIEZO2 test is never a verdict — it is a roadmap for your child’s care. We integrate genetic findings with physical examination, imaging, and family pedigree analysis to build a precise, multidisciplinary treatment plan. Always consult your treating physician before making any changes to prescribed therapies.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Advisory
Do not discontinue prescribed medication or therapy without consulting your treating physician. Genetic test results should be interpreted in the full clinical context by a qualified specialist.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Recent blood transfusion (less than 2 weeks), active systemic infection, or inability to provide informed consent.
- Emergency Red Flags: If your infant develops sudden respiratory distress, severe joint dislocation, or inability to feed, seek immediate emergency care — these may indicate a syndromic progression beyond the genetic diagnosis.
Patient FAQ & Clinical Guidance
1. Which sample types are accepted for the PIEZO2 test, and how is the collection performed at home?
The test accepts whole blood (EDTA or lithium heparin), extracted DNA, or a dried blood spot on an FTA card. Our VIP phlebotomist collects the most suitable specimen during the 8 AM to 11 PM booked appointment using temperature-controlled cold-chain logistics.
2. What is the clinical role of the pre-genetic counselling session?
The mandatory genetic counselling session draws a detailed pedigree chart of family members affected by DA5, identifies inheritance patterns, and ensures you fully understand potential outcomes before testing begins.
3. How soon will I receive my results, and who will interpret them?
Results are typically delivered within 3–4 weeks. A complimentary telephonic interpretation session with a DHA-licensed consultant medical geneticist is scheduled to explain all findings and recommended next steps.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License Number 1143 and complies fully with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical testing, safety protocols, and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic data is encrypted, access-controlled, and never shared without explicit written consent.
Clinical & Logistical Metadata
| Test Name | PIEZO2 Gene Distal Arthrogryposis Type 5 (DA5) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA / Lithium Heparin), Extracted DNA, or Dried Blood Spot (FTA Card) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM to 11 PM. |
| Methodology Used | Next-Generation Sequencing (NGS) on Illumina Platform, >1000x read depth, full gene coverage including exon and intron boundaries. |
| ICD-10-CM Code | Q74.3 |
| LOINC Code | 78843-0 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians